Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes

This study has been completed.
Information provided by (Responsible Party):
Arpita Basu, Oklahoma State University Identifier:
First received: June 24, 2013
Last updated: March 28, 2016
Last verified: December 2014
This study aims to investigate the postprandial effects of cocoa supplementation in glucose and lipids, and surrogate markers of atherosclerosis in patients with type 2 diabetes. The investigators aim to test the hypothesis that cocoa will lower high-fat mixed meal breakfast-induced postprandial rise of glucose, lipids and markers of atherosclerosis in patients with diabetes. Randomized cross-over controlled trial, in which participants will be assigned to the placebo or cocoa group with breakfast meal. Patients with type 2 diabetes(n=25) will qualify for the study. The participants will be asked to consume 2 cups cocoa or placebo beverage on 2 separate postprandial study days. Both groups will receive high-fat mixed meal breakfast on each day. Blood draws and blood pressure (including HDI) measurements will be conducted at fasting, 30 min, 1,2, 4 & 6 hours postprandial each day for 2 days.

Condition Intervention
Type 2 Diabetes
Dietary Supplement: Cocoa polyphenols

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Participant)
Primary Purpose: Prevention
Official Title: Postprandial Effects of Polyphenol-rich Cocoa Beverage on Glucose, Insulin, Lipids, Oxidative Stress and Inflammation in Type 2 Diabetic Patients

Further study details as provided by Oklahoma State University:

Primary Outcome Measures:
  • Blood pressure (mm Hg) [ Time Frame: 2.5 years ]
    Change in blood pressure and vascular function following cocoa and placebo intervention

Secondary Outcome Measures:
  • Glucose (mg/dL) [ Time Frame: 2.5 years ]
    Change in glucose levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa and placebo intervention

Enrollment: 18
Study Start Date: January 2012
Study Completion Date: December 2014
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Cocoa
Cocoa polyphenols (960mg)
Dietary Supplement: Cocoa polyphenols
Cocoa polyphenols (960mg) reconstituted in water
Placebo Comparator: Placebo
Placebo powder (109mg polyphenols) in water
Dietary Supplement: Cocoa polyphenols
Cocoa polyphenols (960mg) reconstituted in water


Ages Eligible for Study:   21 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • clinical diagnosis of type 2diabetes

Exclusion Criteria:

  • on insulin therapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01886989

United States, Oklahoma
Department of Nutritional Sciences
Stillwater, Oklahoma, United States, 74078
Sponsors and Collaborators
Arpita Basu
Principal Investigator: ARPITA BASU, PHD Oklahoma State University
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Arpita Basu, Associate Professor, Oklahoma State University Identifier: NCT01886989     History of Changes
Other Study ID Numbers: HE-12-52
Study First Received: June 24, 2013
Last Updated: March 28, 2016

Keywords provided by Oklahoma State University:
cocoa polyphenols
postprandial glycemia
postprandial lipemia

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases processed this record on May 23, 2017